Skip to main content
. Author manuscript; available in PMC: 2014 Jul 8.
Published in final edited form as: Leuk Lymphoma. 2010 Jan 18;51(3):475–480. doi: 10.3109/10428190903503412

Table IV.

Survival and remission duration by number of adverse factors.

Survival
Remission duration
No. of adverse factors* Patients (n) Median (months) 1-year (%) Median (months) 1-year (%)
0 42 22 72 15 58
1 79 10 40 7 36
2 43 7 26 4 16
3 2 4 0 3 0
*

Adverse factors: age >55 years; duration of first complete response (CR) < 12 months; lactate dehydrogenase (LDH) > 1000 IU/L.